Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta
 

Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta
LONDON (Reuters) - Drugmaker Shire said on Tuesday it was seeking to buy Baxalta , a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist in rare diseases.
http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...4o:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...4o:-BTjWOF_DHI
http://feeds.feedburner.com/~r/reute...~4/sM8YIsmdV9o